ContributorsPublishersAdvertisers

New Ovarian Cancer Treatment Strategies

Cancer Health
Cancer Health
 2021-10-12
Cover picture for the article

Despite breakthrough treatments for high-grade serous ovarian cancer, about 80 percent of patients relapse within two years, often resistant to treatment. The good news is that Dana-Farber scientists are pursuing multiple avenues of research that very well may improve outcomes. “A number of patients develop progressive disease at a...

www.cancerhealth.com

Comments / 0

Comments / 0